Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

EYPTEyePoint, Inc.

Nasdaq · CIK 0001314102
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC3826 Laboratory Analytical Instruments
FY end1231
XBRL facts367

Identity from submissions API

NameEyePoint, Inc.
CIK0001314102
TickersEYPT
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC3826 Laboratory Analytical Instruments
EIN262774444
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone617-926-5000
Website—
Investor website—
Owner org08 Industrial Applications and Services
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • EyePoint Pharmaceuticals, Inc. (2018-04-02T00:00:00.000Z → 2025-12-08T00:00:00.000Z)
  • pSivida Corp. (2008-06-19T00:00:00.000Z → 2018-03-30T00:00:00.000Z)
  • pSivida LTD (2005-01-20T00:00:00.000Z → 2008-06-18T00:00:00.000Z)
Business address
480 PLEASANT STREET
SUITE C400
WATERTOWN
MA
02472
MA
Mailing address
480 PLEASANT STREET
SUITE C400
WATERTOWN
MA
02472
MA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

1352 filing rows loaded from submissions recent; extra archives: CIK0001314102-submissions-001.json (351 filings, 2005-01-20 to 2010-02-09).

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-19 8-K 8-K 8.01 0001193125-26-468558 000-51122 261574835 34 144101 1 1
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001831942-26-000050 005-81613 261560759 34 14334
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001172661-26-005296 005-81613 261559150 34 10390
2026-11-12 10-Q 10-Q 0001193125-26-458319 000-51122 261546839 34 9872330 1 1
2026-11-12 8-K 8-K 2.02,9.01 0001193125-26-456889 000-51122 261543096 34 587291 1 1
2026-11-04 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001623632-26-001650 005-81613 261520088 34 47561
2026-10-30 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0002100119-26-001594 005-81613 261505786 34 7825
2026-10-27 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001214659-26-013297 005-81613 261491930 34 27869
2026-10-19 8-K 8-K 2.02,2.05,8.01,9.01 0001193125-26-424755 000-51122 261467701 34 334955 1 1
2026-10-19 8-K 8-K 8.01,9.01 0001193125-26-424644 000-51122 261467490 34 14039349 1 1
2026-10-07 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001623632-26-001550 005-81613 261445456 34 49483
2026-09-10 8-K 8-K 8.01,9.01 0001193125-26-387197 000-51122 261369619 34 24926154 1 1
2026-09-08 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001274173-26-000222 005-81613 261364130 34 13469
2026-08-24 4 PRIMARY DOCUMENT 0001429932-26-000010 11527
2026-08-18 4 PRIMARY DOCUMENT 0001530968-26-000004 5124
2026-08-17 8-K 8-K 8.01,9.01 0001193125-26-353308 000-51122 261284967 34 15649398 1 1
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001172661-26-003689 005-81613 261279679 34 10356
2026-08-12 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000919574-26-004955 005-81613 261266208 34 15893
2026-08-05 S-8 S-8 0001193125-26-335176 333-298003 261243853 33 506320 1 1
2026-08-05 10-Q 10-Q 0001193125-26-335037 000-51122 261243379 34 9528232 1 1
2026-08-05 8-K 8-K 2.02,9.01 0001193125-26-333821 000-51122 261241295 34 14507783 1 1
2026-07-31 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0002100119-26-001390 005-81613 261226016 34 7723
2026-07-30 8-K 8-K 8.01,9.01 0001193125-26-324866 000-51122 261220139 34 323581 1 1
2026-07-28 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0002012383-26-002491 005-81613 261212543 34 11416
2026-07-22 144/A xsl144X01/primary_doc.xml 0001959173-26-005330 000-51122 261194372 33 5132
2026-07-22 144/A xsl144X01/primary_doc.xml 0001959173-26-005318 000-51122 261193059 33 4840
2026-07-21 144 xsl144X01/primary_doc.xml 0001959173-26-005309 000-51122 261190747 33 16874
2026-07-17 8-K 8-K 1.01,9.01 0001193125-26-307792 000-51122 261183752 34 753756 1 1
2026-07-14 4 PRIMARY DOCUMENT 0001630864-26-000010 10368
2026-07-02 4 PRIMARY DOCUMENT 0002013623-26-000012 14642
2026-06-22 8-K 8-K 5.02,5.07,9.01 0001193125-26-276688 000-51122 261104879 34 268965 1 1
2026-06-03 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001831942-26-000028 005-81613 261061399 34 15237
2026-05-27 4 PRIMARY DOCUMENT 0001429932-26-000008 10377
2026-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-062616 005-81613 26988245 34 12751
2026-05-14 8-K 8-K 8.01,9.01 0001193125-26-222750 000-51122 26975798 34 326128 1 1
2026-05-13 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000919574-26-002911 005-81613 26971191 34 12902
2026-05-07 10-Q 10-Q 0001193125-26-211870 000-51122 26953150 34 8351082 1 1
2026-05-06 8-K 8-K 2.02,9.01 0001193125-26-207537 000-51122 26945777 34 512192 1 1
2026-04-27 DEFA14A DEFA14A 0001193125-26-182077 000-51122 26900940 34 898329
2026-04-27 DEF 14A DEF 14A 0001193125-26-182035 000-51122 26900844 34 4911245 1 1
2026-04-20 4 PRIMARY DOCUMENT 0002013623-26-000010 9020
2026-04-17 144 xsl144X01/primary_doc.xml 0001950047-26-003605 000-51122 26872130 33 6756
2026-04-13 8-K 8-K 8.01,9.01 0001193125-26-152852 000-51122 26857853 34 13962347 1 1
2026-03-26 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000102909-26-001250 005-81613 26800102 34 7463
2026-03-24 4 PRIMARY DOCUMENT 0001630864-26-000008 18328
2026-03-20 8-K 8-K 7.01 0001193125-26-117745 000-51122 26778647 34 143237 1 1
2026-03-16 4 PRIMARY DOCUMENT 0001630864-26-000006 6174
2026-03-06 4 PRIMARY DOCUMENT 0001429932-26-000006 7702
2026-03-05 10-K 10-K 0001193125-26-093917 000-51122 26726108 34 14461553 1 1
2026-03-05 4 PRIMARY DOCUMENT 0002013623-26-000008 9391
2026-03-04 8-K 8-K 2.02,9.01 0001193125-26-089856 000-51122 26718830 34 583315 1 1
2026-03-02 8-K 8-K 8.01,9.01 0001193125-26-084154 000-51122 26703426 34 14637636 1 1
2026-02-24 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-26-019104 005-81613 26671429 34 16470
2026-02-18 4 PRIMARY DOCUMENT 0002013623-26-000006 8874
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001193125-26-054761 005-81613 26641981 34 13705
2026-02-12 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-26-000905 005-81613 26623688 34 12742
2026-01-07 4 PRIMARY DOCUMENT 0001450485-26-000005 8459
2026-01-07 4 PRIMARY DOCUMENT 0001630864-26-000004 10237
2026-01-07 4 PRIMARY DOCUMENT 0001429932-26-000004 10249
2026-01-07 4 PRIMARY DOCUMENT 0002013623-26-000004 9396
2026-01-07 8-K 8-K 2.02,9.01 0001193125-26-005418 000-51122 26513946 34 340389 1 1
2026-01-06 4 PRIMARY DOCUMENT 0002013623-26-000002 13731
2026-01-06 4 PRIMARY DOCUMENT 0001630864-26-000002 20150
2026-01-06 4 PRIMARY DOCUMENT 0001429932-26-000002 20157
2026-01-06 4 PRIMARY DOCUMENT 0001530968-26-000002 5642
2026-01-06 4 PRIMARY DOCUMENT 0002048275-26-000002 5651
2026-01-06 4 PRIMARY DOCUMENT 0001450485-26-000003 10608
2026-01-06 4 PRIMARY DOCUMENT 0001477283-26-000002 5618
2026-01-06 4 PRIMARY DOCUMENT 0001970274-26-000002 5627
2026-01-06 4 PRIMARY DOCUMENT 0001110744-26-000002 5723
2026-01-06 4 PRIMARY DOCUMENT 0001225165-26-000002 5640
2026-01-06 4 PRIMARY DOCUMENT 0001110748-26-000002 5698
2026-01-05 144 xsl144X01/primary_doc.xml 0001950047-26-000143 000-51122 26507153 33 6641
2025-12-23 4 PRIMARY DOCUMENT 0001429932-25-000007 7520
2025-12-08 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000929638-25-004523 005-81613 251556152 34 9121
2025-12-08 4 xslF345X05/form4.xml 0000929638-25-004521 9621
2025-12-08 8-K 8-K 5.03,9.01 0001193125-25-310731 000-51122 251554864 34 155666 1 1
2025-12-05 4 PRIMARY DOCUMENT 0001450485-25-000009 6687
2025-12-04 144 xsl144X01/primary_doc.xml 0001959173-25-007505 000-51122 251548542 33 6434
2025-12-01 4 PRIMARY DOCUMENT 0001450485-25-000007 8162
2025-11-28 144 xsl144X01/primary_doc.xml 0001959173-25-007346 000-51122 251534530 33 5280
2025-11-26 144 xsl144X01/primary_doc.xml 0001959173-25-007319 000-51122 251530270 33 4658
2025-11-19 8-K 8-K 8.01,9.01 0001193125-25-286961 000-51122 251496620 34 175215 1 1
2025-11-13 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-25-004890 005-81613 251475752 34 12638
2025-11-12 4 PRIMARY DOCUMENT 0002013623-25-000005 5718
2025-11-12 144 xsl144X01/primary_doc.xml 0001950047-25-008671 000-51122 251468592 33 5256
2025-11-06 8-K 8-K 8.01,9.01 0001193125-25-270145 000-51122 251459668 34 154313 1 1
2025-11-06 424B5 424B5 0001193125-25-270138 333-290867 251459650 33 1516371 1 1
2025-11-06 10-Q 10-Q 0001193125-25-269471 000-51122 251458226 34 9957326 1 1
2025-11-05 8-K 8-K 2.02,9.01 0001193125-25-265706 000-51122 251451742 34 566096 1 1
2025-10-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0002012383-25-002572 005-81613 251401832 34 11122
2025-10-17 8-K 8-K 1.01,8.01,9.01 0001193125-25-241639 000-51122 251398566 34 648783 1 1
2025-10-16 424B5 424B5 0001193125-25-240658 333-290867 251396312 33 860555 1 1
2025-10-15 FWP FWP 0001193125-25-239375 333-290867 251393253 34 112611
2025-10-14 424B5 424B5 0001193125-25-239161 333-290867 251392644 33 619677
2025-10-14 S-3ASR S-3ASR 0001193125-25-239050 333-290867 251392021 33 985107 1 1
2025-10-14 8-K 8-K 2.02,8.01,9.01 0001193125-25-239008 000-51122 251391813 34 3871386 1 1
2025-09-22 4 PRIMARY DOCUMENT 0001429932-25-000005 7638
2025-08-12 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-25-003516 005-81613 251204592 34 12634
2025-08-07 S-8 S-8 0001193125-25-175479 333-289373 251194691 33 760799 1 1
2025-08-07 10-Q 10-Q 0001193125-25-175418 000-51122 251193890 34 9555988 1 1
2025-08-06 8-K 8-K 2.02,9.01 0000950170-25-103527 000-51122 251187409 34 563807 1 1
2025-07-29 8-K/A 8-K/A 8.01,9.01 0000950170-25-099413 000-51122 251158036 34 14414818 1 1
2025-07-29 8-K 8-K 8.01,9.01 0000950170-25-099383 000-51122 251157509 34 14398243 1 1
2025-07-11 4 PRIMARY DOCUMENT 0001562180-25-005391 7191
2025-07-11 4 PRIMARY DOCUMENT 0001562180-25-005390 8361
2025-07-11 4 PRIMARY DOCUMENT 0001562180-25-005389 10163
2025-07-08 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001623632-25-000780 005-81613 251109525 34 47245
2025-07-02 4 PRIMARY DOCUMENT 0001562180-25-005229 29259
2025-06-25 4 PRIMARY DOCUMENT 0001562180-25-005074 6912
2025-06-20 8-K 8-K 5.02,5.07,9.01 0000950170-25-088169 000-51122 251059061 34 286589 1 1
2025-05-27 4 PRIMARY DOCUMENT 0001562180-25-004193 8969
2025-05-27 8-K 8-K 8.01,9.01 0000950170-25-077373 000-51122 25984171 34 15684529 1 1
2025-05-19 4 PRIMARY DOCUMENT 0001562180-25-003997 6414
2025-05-15 4 PRIMARY DOCUMENT 0001562180-25-003873 7529
2025-05-09 DEFA14A DEFA14A 0000950170-25-067494 000-51122 25928333 34 29769
2025-05-08 10-Q 10-Q 0000950170-25-066907 000-51122 25925926 34 8799411 1 1
2025-05-07 8-K 8-K 2.02,8.01,9.01 0000950170-25-064983 000-51122 25919236 34 15619404 1 1
2025-04-28 DEFA14A DEFA14A 0000950170-25-059303 000-51122 25880405 34 926247
2025-04-28 DEF 14A DEF 14A 0000950170-25-059290 000-51122 25880245 34 7497098 1 1
2025-03-20 4 PRIMARY DOCUMENT 0001562180-25-002626 6918
2025-03-06 10-K 10-K 0000950170-25-034601 000-51122 25715198 34 13617402 1 1
2025-03-05 8-K 8-K 2.02,9.01 0000950170-25-033065 000-51122 25708798 34 580653 1 1
2025-03-04 8-K 8-K 8.01,9.01 0000950170-25-031346 000-51122 25701743 34 15456114 1 1
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001415889-25-004287 005-81613 25631717 34 19204
2025-02-12 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-25-000864 005-81613 25612617 34 12673
2025-02-11 4 PRIMARY DOCUMENT 0001562180-25-001135 7375
2025-02-11 4 PRIMARY DOCUMENT 0001562180-25-001134 8351
2025-02-11 4 PRIMARY DOCUMENT 0001562180-25-001133 10177
2025-02-05 8-K 8-K 8.01,9.01 0000950170-25-014154 000-51122 25590856 34 16009540 1 1
2025-01-27 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000038777-25-000007 005-81613 25556954 34 26150
2025-01-13 8-K 8-K 2.02,8.01,9.01 0000950170-25-004557 000-51122 25524760 34 15039852 1 1
2025-01-08 4 PRIMARY DOCUMENT 0001562180-25-000272 5723
2025-01-08 3 PRIMARY DOCUMENT 0001562180-25-000271 6583
2025-01-08 8-K 8-K 5.02,8.01,9.01 0000950170-25-003280 000-51122 25516567 34 321079 1 1
2025-01-07 4 PRIMARY DOCUMENT 0001562180-25-000235 5658
2025-01-07 4 PRIMARY DOCUMENT 0001562180-25-000234 5589
2025-01-07 4 PRIMARY DOCUMENT 0001562180-25-000233 5501
2025-01-07 4 PRIMARY DOCUMENT 0001562180-25-000232 5562
2025-01-07 4 PRIMARY DOCUMENT 0001562180-25-000231 5454
2025-01-07 4 PRIMARY DOCUMENT 0001562180-25-000230 8108
2025-01-07 4 PRIMARY DOCUMENT 0001562180-25-000229 19074
2025-01-07 4 PRIMARY DOCUMENT 0001562180-25-000228 14262
2025-01-07 4 PRIMARY DOCUMENT 0001562180-25-000227 9276
2025-01-07 4 PRIMARY DOCUMENT 0001562180-25-000226 20097
2024-12-04 8-K 8-K 8.01,9.01 0000950170-24-133076 000-51122 241524792 34 322251 1 1
2024-11-14 SC 13G/A cormorant-eypt093024a2.htm 0001172661-24-005061 005-81613 241460808 34 86773
2024-11-14 SC 13G/A eypt13gasep24.txt 0000080255-24-001396 005-81613 34 6922
2024-11-12 SC 13G/A UnitedStates_13G__EyePointPh.txt 0000932471-24-000983 005-81613 241447011 34 6791
2024-11-12 SC 13G/A p24-3045sc13ga.htm 0000902664-24-006405 005-81613 241444219 34 70814
2024-11-08 SC 13G us30233g2093_110824.txt 0002012383-24-003467 005-81613 241439601 34 14169
2024-11-07 SC 13G SC 13G 0001193125-24-253167 005-81613 241436276 34 81027
2024-11-07 10-Q 10-Q 0000950170-24-123267 000-51122 241435506 34 8795251 1 1
2024-11-07 8-K 8-K 2.02,9.01 0000950170-24-122772 000-51122 241433091 34 492950 1 1
2024-11-06 SC 13G eyepointpharmaceuticals13g.htm 0001623632-24-001866 005-81613 241429374 34 286906
2024-11-04 SC 13G/A UnitedStates_13G__EyePointPh.txt 0000932471-24-000485 005-81613 241421769 34 5830
2024-10-31 8-K 8-K 1.01,8.01,9.01 0001193125-24-248694 000-51122 241415442 34 545998 1 1
2024-10-31 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000038777-24-000157 005-81613 241414150 34 26151
2024-10-30 424B5 424B5 0001193125-24-247581 333-281391 241410630 33 549475
2024-10-28 424B5 424B5 0001193125-24-245679 333-281391 241401887 33 547449
2024-10-28 8-K 8-K 2.02,8.01,9.01 0000950170-24-117568 000-51122 241398422 34 20792121 1 1
2024-10-24 8-K 8-K 8.01,9.01 0000950170-24-116847 000-51122 241390701 34 327905 1 1
2024-10-23 144 xsl144X01/primary_doc.xml 0001950047-24-007857 000-51122 241389581 33 6633
2024-10-22 SC 13G us30233g2093_102224.txt 0002012383-24-001254 005-81613 241386153 34 14157
2024-10-15 144 xsl144X01/primary_doc.xml 0001968582-24-000930 000-51122 241370770 33 5512
2024-09-05 3 PRIMARY DOCUMENT 0001562180-24-006672 6583
2024-09-05 4 PRIMARY DOCUMENT 0001562180-24-006671 5798
2024-09-04 8-K 8-K 5.02,8.01,9.01 0000950170-24-103097 000-51122 241275844 34 195800 1 1
2024-08-21 4 PRIMARY DOCUMENT 0001562180-24-006440 5358
2024-08-21 4 PRIMARY DOCUMENT 0001562180-24-006432 4846
2024-08-21 4 PRIMARY DOCUMENT 0001562180-24-006431 5495
2024-08-20 4 PRIMARY DOCUMENT 0001562180-24-006378 6647
2024-08-16 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2024-08-16 16:00:00 9999999995-24-002568 333-281391 241218141 33 1986
2024-08-14 CORRESP filename1.htm 0001193125-24-200746 7424
2024-08-14 UPLOAD filename1.pdf 0000000000-24-009295 333-281391 40407
2024-08-08 S-8 S-8 0001193125-24-197032 333-281393 241189225 33 124310
2024-08-08 S-3 S-3 0001193125-24-197029 333-281391 241189170 33 1058777
2024-08-08 10-Q 10-Q 0000950170-24-093853 000-51122 241188036 34 8536336 1 1
2024-08-07 8-K 8-K 2.02,9.01 0000950170-24-092262 000-51122 241181356 34 476041 1 1
2024-07-26 4 PRIMARY DOCUMENT 0001562180-24-005854 29142
2024-07-16 4 PRIMARY DOCUMENT 0001562180-24-005752 12719
2024-07-12 4 PRIMARY DOCUMENT 0001562180-24-005701 10184
2024-07-12 4 PRIMARY DOCUMENT 0001562180-24-005700 8380
2024-07-12 4 PRIMARY DOCUMENT 0001562180-24-005698 7203
2024-06-26 8-K 8-K 2.02,8.01,9.01 0000950170-24-077636 000-51122 241070875 34 28251178 1 1
2024-06-25 4 PRIMARY DOCUMENT 0001562180-24-005299 7176
2024-06-21 8-K 8-K 5.02,5.07,9.01 0000950170-24-075872 000-51122 241058336 34 562705 1 1
2024-06-04 4 PRIMARY DOCUMENT 0001562180-24-004638 12730
2024-05-28 4 PRIMARY DOCUMENT 0001562180-24-004462 8978
2024-05-28 8-K 8-K 8.01,9.01 0000950170-24-064879 000-51122 24986252 34 19160499 1 1
2024-05-16 4 PRIMARY DOCUMENT 0001562180-24-004106 12718
2024-05-14 144 xsl144X01/primary_doc.xml 0001968582-24-000375 000-51122 24945141 33 6365
2024-05-09 10-Q 10-Q 0000950170-24-056380 000-51122 24929088 34 7822958 1 1
2024-05-08 4 xslF345X05/form4.xml 0000929638-24-001743 11368
2024-05-08 8-K 8-K 2.02,9.01 0000950170-24-055055 000-51122 24924206 34 365072 1 1
2024-05-06 8-K 8-K 8.01,9.01 0000950170-24-053248 000-51122 24916113 34 9418395 1 1
2024-05-01 SC 13G/A EYEPOINT PHARMACEUTICALS, INC. 0000902664-24-003135 005-81613 24904006 34 75880
2024-04-30 SC 13G EYEPOINT PHARMACEUTICALS, INC. 0000902664-24-003112 005-81613 24899601 34 73051
2024-04-26 DEF 14A DEF 14A 0000950170-24-049067 000-51122 24883374 34 2933932
2024-04-26 DEFA14A DEFA14A 0000950170-24-049068 000-51122 24883372 34 432808
2024-04-22 3 xslF345X02/ownership.xml 0000902664-24-003016 8325
2024-04-22 4 xslF345X05/form4.xml 0000929638-24-001536 11368
2024-04-02 4 PRIMARY DOCUMENT 0001562180-24-003193 19564
2024-03-08 10-K 10-K 0000950170-24-028523 000-51122 24733597 34 12362483 1 1
2024-03-07 8-K 8-K 2.02,9.01 0000950170-24-027582 000-51122 24728132 34 393443 1 1
2024-03-04 4 PRIMARY DOCUMENT 0001562180-24-002119 5840
2024-03-04 3 PRIMARY DOCUMENT 0001562180-24-002118 6473
2024-03-04 8-K 8-K 8.01,9.01 0000950170-24-024346 000-51122 24712818 34 212872 1 1
2024-02-28 4 PRIMARY DOCUMENT 0001562180-24-001895 7267
2024-02-22 4 PRIMARY DOCUMENT 0001562180-24-001624 7269
2024-02-14 SC 13G/A SC 13G/A 0001104659-24-024252 005-81613 24641758 34 93134
2024-02-14 SC 13G eypt13gdec23.txt 0000080255-24-000689 005-81613 34 6723
2024-02-13 4 PRIMARY DOCUMENT 0001562180-24-001294 33613
2024-02-13 4 PRIMARY DOCUMENT 0001562180-24-001293 14292
2024-02-13 4 PRIMARY DOCUMENT 0001562180-24-001292 14541
2024-02-13 4 PRIMARY DOCUMENT 0001562180-24-001291 14458
2024-02-13 4 PRIMARY DOCUMENT 0001562180-24-001290 14304
2024-02-13 SC 13G/A d10963055_13g-a.htm 0000919574-24-000946 005-81613 24623811 34 122879
2024-02-07 SC 13G/A EYEPOINT PHARMACEUTICALS, INC. 0000902664-24-001182 005-81613 24602210 34 94918
2024-02-06 SC 13G/A eyep23a5.htm 0000038777-24-000013 005-81613 24598863 34 186035
2024-02-05 4 PRIMARY DOCUMENT 0001562180-24-001050 8836
2024-02-02 144 xsl144X01/primary_doc.xml 0001950047-24-000622 000-51122 24591795 33 8699
2024-01-30 4 PRIMARY DOCUMENT 0001562180-24-000808 20339
2024-01-29 4 PRIMARY DOCUMENT 0001562180-24-000785 15242
2024-01-29 4 PRIMARY DOCUMENT 0001562180-24-000784 14051
2024-01-26 4 PRIMARY DOCUMENT 0001562180-24-000673 25460
2024-01-25 4 PRIMARY DOCUMENT 0001562180-24-000637 24898
2024-01-25 4 PRIMARY DOCUMENT 0001562180-24-000636 13914
2024-01-24 4 PRIMARY DOCUMENT 0001562180-24-000581 25866
2024-01-24 144 xsl144X01/primary_doc.xml 0001959173-24-000450 000-51122 24556819 33 7728
2024-01-24 144 xsl144X01/primary_doc.xml 0001950047-24-000442 000-51122 24556658 33 6429
2024-01-23 144 xsl144X01/primary_doc.xml 0001959173-24-000432 000-51122 24553145 33 6492
2024-01-23 144 xsl144X01/primary_doc.xml 0001950047-24-000426 000-51122 24552891 33 7123
2024-01-22 144 xsl144X01/primary_doc.xml 0001950047-24-000405 000-51122 24549084 33 5155
2024-01-16 4 PRIMARY DOCUMENT 0001840315-24-000002 5206
2024-01-16 4 PRIMARY DOCUMENT 0001562180-24-000466 5436
2024-01-11 144 xsl144X01/primary_doc.xml 0001840315-24-000001 000-51122 24530072 33 5590
2024-01-11 4 xslF345X05/form4.xml 0000929638-24-000081 10814
2024-01-10 4 PRIMARY DOCUMENT 0001562180-24-000414 9331
2024-01-10 8-K 8-K 2.02,8.01,9.01 0000950170-24-003512 000-51122 24524850 34 22642247 1 1
2024-01-09 4 PRIMARY DOCUMENT 0001562180-24-000403 13631
2024-01-09 4 PRIMARY DOCUMENT 0001562180-24-000402 13635
2024-01-09 4 PRIMARY DOCUMENT 0001562180-24-000401 5590
2024-01-09 4 PRIMARY DOCUMENT 0001562180-24-000400 13668
2024-01-09 4 PRIMARY DOCUMENT 0001562180-24-000399 13879
2024-01-09 4 PRIMARY DOCUMENT 0001562180-24-000398 13646
2024-01-09 4 PRIMARY DOCUMENT 0001562180-24-000397 13803
2024-01-09 4 PRIMARY DOCUMENT 0001562180-24-000396 5557
2024-01-09 4 PRIMARY DOCUMENT 0001562180-24-000395 9838
2024-01-09 4 PRIMARY DOCUMENT 0001562180-24-000394 5563
2024-01-09 4 PRIMARY DOCUMENT 0001562180-24-000393 5455
2024-01-09 4 PRIMARY DOCUMENT 0001562180-24-000392 5502
2024-01-09 4 PRIMARY DOCUMENT 0001562180-24-000391 5563
2024-01-03 4/A PRIMARY DOCUMENT 0001562180-24-000133 24423
2024-01-02 4 PRIMARY DOCUMENT 0001562180-24-000035 20756
2023-12-15 4 PRIMARY DOCUMENT 0001562180-23-008415 8674
2023-12-14 SC 13G/A AMENDMENT NO. 1 0000929638-23-003426 005-81613 231487074 34 79565
2023-12-12 4 xslF345X05/form4.xml 0000929638-23-003419 8522
2023-12-11 4/A PRIMARY DOCUMENT 0001562180-23-008273 10698
2023-12-08 SC 13D/A SC 13D/A 0001193125-23-291815 005-81613 231476435 34 195637
2023-12-08 8-K 8-K 8.01,9.01 0001193125-23-291662 000-51122 231475342 34 196882 1 1
2023-12-08 8-K 8-K 1.01,8.01,9.01 0001193125-23-290820 000-51122 231473552 34 510814 1 1
2023-12-07 4 PRIMARY DOCUMENT 0001840315-23-000007 7406
2023-12-07 4 PRIMARY DOCUMENT 0001562180-23-008222 8111
2023-12-07 424B5 424B5 0001193125-23-290270 333-275125 231471021 33 643735
2023-12-06 4 PRIMARY DOCUMENT 0001562180-23-008172 8947
2023-12-06 4 PRIMARY DOCUMENT 0001562180-23-008171 8681
2023-12-06 4 PRIMARY DOCUMENT 0001562180-23-008170 5384
2023-12-06 4 xslF345X05/form4.xml 0000929638-23-003383 38477
2023-12-06 3 xslF345X02/form3.xml 0000929638-23-003382 7890
2023-12-05 144 xsl144X01/primary_doc.xml 0001840315-23-000006 000-51122 231465318 33 4890
2023-12-04 424B5 424B5 0001193125-23-288522 333-275125 231464489 33 642571
2023-12-04 144/A xsl144X01/primary_doc.xml 0001959173-23-005181 000-51122 231463710 33 8185
2023-12-04 144 xsl144X01/primary_doc.xml 0001950047-23-005612 000-51122 231463247 33 4877
2023-12-04 144 xsl144X01/primary_doc.xml 0001950047-23-005610 000-51122 231463230 33 5492
2023-12-04 144 xsl144X01/primary_doc.xml 0001959173-23-005166 000-51122 231462802 33 7905
2023-12-04 8-K 8-K 8.01,9.01 0000950170-23-067468 000-51122 231461302 34 12908170 1 1
2023-11-09 8-K 8-K 8.01,9.01 0000950170-23-061549 000-51122 231390129 34 12526802 1 1
2023-11-03 10-Q 10-Q 0000950170-23-058775 000-51122 231376145 34 9534302 1 1
2023-11-01 8-K 8-K 2.02,9.01 0000950170-23-057119 000-51122 231366523 34 476274 1 1
2023-10-30 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2023-10-30 16:00:00 9999999995-23-003140 333-275125 231362140 33 1914
2023-10-26 CORRESP filename1.htm 0001193125-23-263644 6326
2023-10-25 UPLOAD filename1.pdf 0000000000-23-011689 40485
2023-10-20 S-3 S-3 0001193125-23-260012 333-275125 231337781 33 797151
2023-10-20 S-8 S-8 0001193125-23-260008 333-275124 231337757 33 120076
2023-10-17 4 PRIMARY DOCUMENT 0001562180-23-007327 5595
2023-10-17 3 PRIMARY DOCUMENT 0001562180-23-007326 6420
2023-10-17 4 PRIMARY DOCUMENT 0001562180-23-007325 5689
2023-10-16 8-K 8-K 5.02,8.01,9.01 0000950170-23-053406 000-51122 231326191 34 208673 1 1
2023-09-13 8-K 8-K 8.01,9.01 0000950170-23-047829 000-51122 231251597 34 18732647 1 1
2023-09-11 SC 13G/A eyep23a4.htm 0000038777-23-000132 005-81613 231247126 34 217757
2023-09-11 8-K 8-K 8.01,9.01 0000950170-23-047354 000-51122 231246674 34 203641 1 1
2023-09-06 4/A FORM 4/A SUBMISSION 0000899243-23-018661 12931
2023-09-06 4 FORM 4 SUBMISSION 0000899243-23-018658 12639
2023-09-01 4 FORM 4 SUBMISSION 0000899243-23-018636 19473
2023-08-30 4 FORM 4 SUBMISSION 0000899243-23-018610 16756
2023-08-30 4/A FORM 4/A SUBMISSION 0000899243-23-018606 20020
2023-08-30 SC 13D/A SC 13D/A 0001193125-23-225037 005-81613 231226172 34 249962
2023-08-28 4 4 0000950170-23-044843 15319
2023-08-24 4 FORM 4 SUBMISSION 0000899243-23-018380 14078
2023-08-22 144 xsl144X01/primary_doc.xml 0001969223-23-000317 000-51122 231193806 33 5693
2023-08-22 144 xsl144X01/primary_doc.xml 0001969223-23-000316 000-51122 231193702 33 5797
2023-08-04 10-Q 10-Q 0000950170-23-038514 000-51122 231143649 34 10387873 1 1
2023-08-02 8-K 8-K 2.02,9.01 0000950170-23-036770 000-51122 231133699 34 523163 1 1
2023-07-27 8-K 8-K 8.01,9.01 0000950170-23-035133 000-51122 231118441 34 9689327 1 1
2023-07-12 4 PRIMARY DOCUMENT 0001562180-23-005881 7992
2023-07-12 4 PRIMARY DOCUMENT 0001562180-23-005880 7977
2023-07-12 4 PRIMARY DOCUMENT 0001562180-23-005879 7095
2023-07-11 8-K 8-K 8.01,9.01 0000950170-23-032444 000-51122 231081195 34 16661594 1 1
2023-07-10 8-K 8-K 5.02,8.01,9.01 0000950170-23-032324 000-51122 231078217 34 323924 1 1
2023-06-26 4 PRIMARY DOCUMENT 0001562180-23-005502 7073
2023-06-22 4 PRIMARY DOCUMENT 0001562180-23-005451 7596
2023-06-22 4 PRIMARY DOCUMENT 0001562180-23-005450 7593
2023-06-22 4 PRIMARY DOCUMENT 0001562180-23-005449 7494
2023-06-22 4 PRIMARY DOCUMENT 0001562180-23-005448 7541
2023-06-22 4 PRIMARY DOCUMENT 0001562180-23-005447 7602
2023-06-22 4 PRIMARY DOCUMENT 0001562180-23-005446 7629
2023-06-22 4 PRIMARY DOCUMENT 0001562180-23-005445 5652
2023-06-22 4 PRIMARY DOCUMENT 0001562180-23-005444 5678
2023-06-22 4 PRIMARY DOCUMENT 0001562180-23-005443 5615
2023-06-22 4 PRIMARY DOCUMENT 0001562180-23-005442 5595
2023-06-22 4 PRIMARY DOCUMENT 0001562180-23-005441 5601
2023-06-22 4 PRIMARY DOCUMENT 0001562180-23-005440 5628
2023-06-21 8-K 8-K 5.02,5.07,9.01 0000950170-23-029066 000-51122 231027421 34 463042 1 1
2023-06-05 8-K 8-K 8.01,9.01 0000950170-23-026230 000-51122 23991211 34 16815194 1 1
2023-05-31 4 PRIMARY DOCUMENT 0001562180-23-004632 5437
2023-05-30 4 PRIMARY DOCUMENT 0001562180-23-004580 7991
2023-05-30 4 PRIMARY DOCUMENT 0001562180-23-004579 7937
2023-05-26 144/A xsl144X01/primary_doc.xml 0001840315-23-000005 000-51122 23963956 33 5232
2023-05-26 144/A xsl144X01/primary_doc.xml 0001840315-23-000004 000-51122 23963672 33 5294
2023-05-26 144 xsl144X01/primary_doc.xml 0001968940-23-000001 000-51122 23963013 33 4888
2023-05-23 8-K/A 8-K/A 9.01 0001193125-23-151951 000-51122 23949908 34 347570 1 1
2023-05-18 8-K 8-K 1.01,1.02,2.01,2.05,8.01,9.01 0000950170-23-022872 000-51122 23933683 34 1605749 1 1
2023-05-15 4 PRIMARY DOCUMENT 0001562180-23-004132 40947
2023-05-04 10-Q 10-Q 0000950170-23-017724 000-51122 23888021 34 9950823 1 1
2023-05-03 8-K 8-K 2.02,9.01 0000950170-23-016879 000-51122 23881634 34 445320 1 1
2023-05-01 SC 13G/A schedule13g.htm 0000929638-23-001329 005-81613 23874038 34 97922
2023-04-28 DEFA14A DEFA14A 0000950170-23-015757 000-51122 23865752 34 3509593
2023-04-28 DEF 14A DEF 14A 0000950170-23-015754 000-51122 23865723 34 5625152
2023-03-27 8-K 8-K 8.01,9.01 0000950170-23-009850 000-51122 23761428 34 210684 1 1
2023-03-10 8-K 8-K 8.01 0000950170-23-007373 000-51122 23725006 34 165283 1 1
2023-03-10 10-K 10-K 0000950170-23-007180 000-51122 23722714 34 17814257 1 1
2023-03-02 8-K 8-K 2.02,9.01 0000950170-23-005701 000-51122 23696391 34 515679 1 1
2023-02-14 SC 13G/A SC 13G/A 0001104659-23-021820 005-81613 23630726 34 89216
2023-02-13 4 PRIMARY DOCUMENT 0001562180-23-001338 6990
2023-02-13 4 PRIMARY DOCUMENT 0001562180-23-001337 14146
2023-02-13 4 PRIMARY DOCUMENT 0001562180-23-001336 6888
2023-02-13 4 PRIMARY DOCUMENT 0001562180-23-001335 6988
2023-02-13 4 PRIMARY DOCUMENT 0001562180-23-001334 6935
2023-02-13 4 PRIMARY DOCUMENT 0001562180-23-001333 14153
2023-02-13 4 PRIMARY DOCUMENT 0001562180-23-001332 14429
2023-02-13 4 PRIMARY DOCUMENT 0001562180-23-001331 10886
2023-02-13 4 PRIMARY DOCUMENT 0001562180-23-001330 10987
2023-02-13 SC 13G/A d9927863_13g-a.htm 0000919574-23-000961 005-81613 23615438 34 110268
2023-01-31 SC 13G/A eyep22a31.htm 0000038777-23-000019 005-81613 23570987 34 233646
2023-01-23 8-K 8-K 1.01,2.03,8.01,9.01 0000950170-23-000990 000-51122 23542522 34 213164 1 1
2023-01-12 8-K 8-K 8.01,9.01 0000950170-23-000722 000-51122 23526337 34 17461617 1 1
2023-01-10 4 PRIMARY DOCUMENT 0001562180-23-000347 5644
2023-01-10 4 PRIMARY DOCUMENT 0001562180-23-000346 5674
2023-01-10 4 PRIMARY DOCUMENT 0001562180-23-000345 5638
2023-01-10 4 PRIMARY DOCUMENT 0001562180-23-000344 5721
2023-01-10 4 PRIMARY DOCUMENT 0001562180-23-000343 5695
2023-01-10 4 PRIMARY DOCUMENT 0001562180-23-000342 5658
2023-01-09 S-8 S-8 0001193125-23-004810 333-269167 23518651 33 126975
2023-01-06 8-K 8-K 2.02,5.02,8.01,9.01 0000950170-23-000355 000-51122 23515809 34 798913 1 1
2022-11-16 8-K 8-K 8.01,9.01 0000950170-22-025259 000-51122 221394015 34 3203382 1 1
2022-11-14 8-K 8-K 5.02,5.07,9.01 0000950170-22-024735 000-51122 221380612 34 381006 1 1
2022-11-04 10-Q 10-Q 0000950170-22-022141 000-51122 221361464 34 11865261 1 1
2022-11-03 4 PRIMARY DOCUMENT 0001562180-22-007459 8845
2022-11-02 8-K 8-K 2.02,9.01 0000950170-22-020968 000-51122 221352263 34 523065 1 1
2022-10-11 8-K 8-K 1.02 0000950170-22-019449 000-51122 221304832 34 163657 1 1
2022-09-29 8-K 8-K 8.01,9.01 0000950170-22-018990 000-51122 221277687 34 204120 1 1
2022-09-28 DEFA14A DEFA14A 0000950170-22-018963 000-51122 221276245 34 226960
2022-09-28 DEF 14A DEF 14A 0000950170-22-018962 000-51122 221276206 34 1437621
2022-09-28 8-K 8-K 8.01,9.01 0000950170-22-018953 000-51122 221273470 34 3041568 1 1
2022-09-16 PRE 14A PRE 14A 0000950170-22-018607 000-51122 221248202 34 1437601
2022-09-09 4 PRIMARY DOCUMENT 0001562180-22-006581 5695
2022-09-09 4/A PRIMARY DOCUMENT 0001562180-22-006580 6122
2022-08-30 8-K 8-K 8.01 0000950170-22-017914 000-51122 221214816 34 160993 1 1
2022-08-05 10-Q 10-Q 0000950170-22-015071 000-51122 221140028 34 12378867 1 1
2022-08-03 8-K 8-K 2.02,9.01 0000950170-22-014006 000-51122 221130891 34 509632 1 1
2022-07-18 8-K 8-K 2.02,8.01,9.01 0000950170-22-012766 000-51122 221089694 34 5832768 1 1
2022-07-14 8-K 8-K 5.02,8.01,9.01 0000950170-22-012679 000-51122 221082526 34 204163 1 1
2022-07-13 4 PRIMARY DOCUMENT 0001562180-22-005662 7845
2022-07-13 3 PRIMARY DOCUMENT 0001562180-22-005661 6423
2022-06-27 4 PRIMARY DOCUMENT 0001562180-22-005368 7818
2022-06-27 3 PRIMARY DOCUMENT 0001562180-22-005367 6363
2022-06-24 8-K 8-K 5.07 0001564590-22-024134 000-51122 221038270 34 234841 1 1
2022-05-13 8-K 8-K 8.01,9.01 0001564590-22-020081 000-51122 22921868 34 17261851 1 1
2022-05-06 10-Q 10-Q 0001564590-22-018528 000-51122 22900255 34 9640328 1 1
2022-05-04 8-K 8-K 2.02,9.01 0001564590-22-017673 000-51122 22889846 34 416507 1 1
2022-04-28 DEFA14A DEFA14A 0001564590-22-016395 000-51122 22866019 34 224687
2022-04-28 DEF 14A DEF 14A 0001564590-22-016389 000-51122 22865920 34 3422263
2022-03-15 4 PRIMARY DOCUMENT 0001562180-22-002643 4829
2022-03-14 10-K 10-K 0001564590-22-009929 000-51122 22734769 34 16395338 1 1
2022-03-03 8-K 8-K 2.02,9.01 0001564590-22-008401 000-51122 22706721 34 486254 1 1
2022-03-02 4 PRIMARY DOCUMENT 0001562180-22-002137 8947
2022-03-02 4 PRIMARY DOCUMENT 0001562180-22-002136 8884
2022-03-02 4 PRIMARY DOCUMENT 0001562180-22-002135 7089
2022-02-23 4 PRIMARY DOCUMENT 0001562180-22-001757 7069

Latest XBRL company facts

One latest value per concept from companyfacts (367 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 113.78M 2026-11-06 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
dei EntityPublicFloat Entity Public Float USD 642.60M 2025-06-30 2025 FY 10-K 2026-03-05 0001193125-26-093917
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 4.96M 2025-01-01 2025-12-31 DEF 14A 2026-04-27 0001193125-26-182035
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 2.17M 2025-01-01 2025-12-31 DEF 14A 2026-04-27 0001193125-26-182035
ecd PeoActuallyPaidCompAmt PeoActuallyPaidCompAmt USD 13.99M 2025-01-01 2025-12-31 DEF 14A 2026-04-27 0001193125-26-182035
ecd PeoTotalCompAmt PeoTotalCompAmt USD 5.57M 2025-01-01 2025-12-31 DEF 14A 2026-04-27 0001193125-26-182035
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 522 2025-01-01 2025-12-31 DEF 14A 2026-04-27 0001193125-26-182035
ffd NetFeeAmt NetFeeAmt USD 11,157.4 2026-08-04 S-8 2026-08-05 0001193125-26-335176
ffd TtlFeeAmt TtlFeeAmt USD 11,157.4 2026-08-04 S-8 2026-08-05 0001193125-26-335176
ffd TtlOfferingAmt TtlOfferingAmt USD 80.79M 2026-08-04 S-8 2026-08-05 0001193125-26-335176
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-08-04 S-8 2026-08-05 0001193125-26-335176
us-gaap AccountsAndOtherReceivablesNetCurrent Accounts and Other Receivables, Net, Current USD 259,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 15.25M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap AccruedIncomeTaxes Accrued Income Taxes USD 260,000 2014-09-30 2015 Q1 10-Q 2014-11-07 0001193125-14-402794
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 20.51M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap AccruedLiabilitiesForCommissionsExpenseAndTaxes Accrued Liabilities for Commissions, Expense and Taxes USD 0 2023-06-30 2023 Q2 10-Q 2023-08-04 0000950170-23-038514
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 1.24M 2025-06-30 2025 Q2 10-Q 2025-08-07 0001193125-25-175418
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 6.02M 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093917
us-gaap AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax USD 900,000 2023-12-31 2023 FY 10-K 2024-03-08 0000950170-24-028523
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD 814,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 292.44M 2015-03-31 2015 Q3 10-Q 2015-05-08 0001193125-15-179302
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 1.49B 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 33.90M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD 300,000 2019-04-01 2019 Q1 10-Q 2019-05-10 0001193125-19-144237
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 355,000 2017-07-01 2018-06-30 2019 FY 10-K 2020-03-16 0001564590-20-010956
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 33.90M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap AllowanceForDoubtfulAccountsReceivable Accounts Receivable, Allowance for Credit Loss USD 0 2019-09-30 2019 Q3 10-Q 2019-11-07 0001564590-19-041819
us-gaap AllowanceForDoubtfulAccountsReceivableCurrent Accounts Receivable, Allowance for Credit Loss, Current USD 0 2019-12-31 2019 FY 10-K 2020-03-16 0001564590-20-010956
us-gaap AmortizationOfDebtDiscountPremium Amortization of Debt Discount (Premium) USD -9,000 2016-07-01 2017-06-30 2019 FY 10-K 2020-03-16 0001564590-20-010956
us-gaap AmortizationOfIntangibleAssets Amortization of Intangible Assets USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-08 0000950170-24-028523
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 13.25M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap Assets Assets USD 166.14M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap AssetsCurrent Assets, Current USD 126.99M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap AssetsFairValueDisclosure Assets, Fair Value Disclosure USD 9.70M 2013-06-30 2013 FY 10-K 2013-09-27 0001193125-13-382009
us-gaap AssetsFairValueDisclosureNonrecurring Assets, Fair Value Disclosure, Nonrecurring (Deprecated 2018-01-31) USD 0 2014-06-30 2014 FY 10-K 2014-09-11 0001193125-14-338993
us-gaap AssetsFairValueDisclosureRecurring Assets, Fair Value Disclosure, Recurring (Deprecated 2018-01-31) USD 6.80M 2018-03-31 2018 Q3 10-Q 2018-05-10 0001193125-18-159375
us-gaap AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax USD 2,000 2016-06-30 2017 FY 10-K 2017-09-13 0001193125-17-283875
us-gaap AvailableForSaleSecuritiesAmortizedCost Available-for-sale Securities, Amortized Cost Basis USD 13.68M 2016-06-30 2017 FY 10-K 2017-09-13 0001193125-17-283875
us-gaap AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value USD 0 2018-06-30 2018 FY 10-K 2018-09-18 0001193125-18-276414
us-gaap AvailableForSaleSecuritiesCurrent Available-for-sale Securities, Current USD 0 2020-12-31 2020 FY 10-K 2021-03-12 0001564590-21-012894
us-gaap AvailableForSaleSecuritiesDebtSecuritiesCurrent Debt Securities, Available-for-sale, Current USD 33.00M 2021-12-31 2021 FY 10-K 2022-03-14 0001564590-22-009929
us-gaap AvailableForSaleSecuritiesFairValueDisclosure Available-for-sale Securities, Fair Value Disclosure (Deprecated 2013-01-31) USD 6.31M 2012-12-31 2013 Q2 10-Q 2013-02-08 0001193125-13-045326
us-gaap AvailableForSaleSecuritiesGrossUnrealizedGainLoss Available-for-sale Securities, Gross Unrealized Gain (Loss) (Deprecated 2013-01-31) USD -5,000 2013-03-31 2013 Q3 10-Q 2013-05-14 0001193125-13-219166
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 120,000 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-05 0001193125-26-335037
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 83.21M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD -552,000 2017-07-01 2018-03-31 2018 Q3 10-Q 2018-05-10 0001193125-18-159375
us-gaap CashCashEquivalentsAndShortTermInvestments Cash, Cash Equivalents, and Short-term Investments USD 118.20M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 83.36M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -18.61M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap CashEquivalentsAtCarryingValue Cash Equivalents, at Carrying Value USD 6.80M 2018-03-31 2018 Q3 10-Q 2018-05-10 0001193125-18-159375
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 12.33 2024-12-31 2024 FY 10-K 2025-03-06 0000950170-25-034601
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 48,683 2023-03-31 2023 Q1 10-Q 2023-05-04 0000950170-23-017724
us-gaap CommercialPaperAtCarryingValue Commercial Paper, at Carrying Value USD 5.00M 2023-12-31 2024 FY 10-K 2025-03-06 0000950170-25-034601
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 300.00M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 90.77M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 90.77M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap CommonStockValue Common Stock, Value, Issued USD 91,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -275.06M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap ConcentrationRiskPercentage1 Concentration Risk, Percentage pure 0.1 2018-07-01 2018-12-31 2018 FY 10-KT 2019-03-18 0001193125-19-078454
us-gaap ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss Contract with Customer, Asset, Allowance for Credit Loss USD 62,000 2025-09-30 2025 Q3 10-Q 2025-11-06 0001193125-25-269471
us-gaap ConversionOfStockSharesConverted1 Conversion of Stock, Shares Converted shares 1 2020-12-08 2020 FY 10-K 2021-03-12 0001564590-21-012894
us-gaap CostOfGoodsAndServicesSold Cost of Goods and Services Sold USD 2.90M 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-07 0000950170-24-123267
us-gaap CostsAndExpenses Costs and Expenses USD 132.30M 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-07 0000950170-24-123267
us-gaap CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption Cumulative Effect of New Accounting Principle in Period of Adoption (Deprecated 2020-01-31) USD 218,000 2018-12-31 2018 FY 10-KT 2019-03-18 0001193125-19-078454
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD 263,000 2014-07-01 2015-06-30 2017 FY 10-K 2017-09-13 0001193125-17-283875
us-gaap CurrentForeignTaxExpenseBenefit Current Foreign Tax Expense (Benefit) USD 159,000 2015-07-01 2016-06-30 2018 FY 10-KT 2019-03-18 0001193125-19-078454
us-gaap DebtInstrumentFeeAmount Debt Instrument, Fee Amount USD 2.10M 2019-03-31 2019 Q1 10-Q 2019-05-10 0001193125-19-144237
us-gaap DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction USD 222,000 2019-01-01 2019-03-31 2020 Q1 10-Q 2020-05-08 0001564590-20-023640
us-gaap DeferredFederalIncomeTaxExpenseBenefit Deferred Federal Income Tax Expense (Benefit) USD -13,000 2011-07-01 2012-06-30 2013 FY 10-K 2013-09-27 0001193125-13-382009
us-gaap DeferredForeignIncomeTaxExpenseBenefit Deferred Foreign Income Tax Expense (Benefit) USD 0 2014-07-01 2015-06-30 2015 FY 10-K 2015-09-10 0001193125-15-316983
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 5.49M 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093917
us-gaap DeferredRentCreditNoncurrent Deferred Rent Credit, Noncurrent USD 42,000 2017-12-31 2018 Q2 10-Q 2018-02-08 0001193125-18-036206
us-gaap DeferredRevenue Deferred Revenue USD 15,000 2018-12-31 2018 FY 10-KT 2019-03-18 0001193125-19-078454
us-gaap DeferredRevenueCurrent Deferred Revenue, Current USD 0 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093917
us-gaap DeferredRevenueNoncurrent Deferred Revenue, Noncurrent USD 0 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093917
us-gaap DeferredTaxAssetsDeferredIncome Deferred Tax Assets, Deferred Income USD 0 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093917
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 257.63M 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093917
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093917
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 115.21M 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093917
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 5.28M 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093917
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 17.14M 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093917
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 23.25M 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093917
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsProvisionForLoanLosses Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Provision for Loan Losses USD 0 2015-06-30 2015 FY 10-K 2015-09-10 0001193125-15-316983
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 252.15M 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093917
us-gaap DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets Deferred Tax Liabilities, Intangible Assets USD 0 2022-12-31 2022 FY 10-K 2023-03-10 0000950170-23-007180
us-gaap DeferredTaxLiabilitiesLeasingArrangements Deferred Tax Liabilities, Leasing Arrangements USD 5.49M 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093917
us-gaap DeferredTaxLiabilitiesNoncurrent Deferred Tax Liabilities, Net, Noncurrent USD 13,000 2011-06-30 2012 FY 10-K 2012-09-27 0001193125-12-406956
us-gaap DefinedContributionPlanEmployerDiscretionaryContributionAmount Defined Contribution Plan, Employer Discretionary Contribution Amount USD 2.30M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093917
us-gaap DefinedContributionPlanEmployerMatchingContributionPercent Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay pure 0.06 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093917
us-gaap Depreciation Depreciation USD 2.10M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093917
us-gaap DepreciationAndAmortization Depreciation, Depletion and Amortization, Nonproduction USD 2.09M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 2.09M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap DerivativeFinancialInstrumentsLiabilitiesFairValueDisclosure Derivative Financial Instruments, Liabilities, Fair Value Disclosure (Deprecated 2013-01-31) USD 170,000 2011-06-30 2012 FY 10-K 2012-09-27 0001193125-12-406956
us-gaap DerivativeLiabilities Derivative Liability USD 6.96M 2018-03-31 2018 Q3 10-Q 2018-05-10 0001193125-18-159375
us-gaap DerivativeLiabilitiesCurrent Derivative Liability, Current USD 170,000 2011-06-30 2012 FY 10-K 2012-09-27 0001193125-12-406956
us-gaap DerivativeLiabilitiesNoncurrent Derivative Liability, Noncurrent USD 0 2018-12-31 2018 FY 10-KT 2019-03-18 0001193125-19-078454
us-gaap DueFromRelatedPartiesCurrent Due from Related Parties, Current USD 414,000 2021-12-31 2021 FY 10-K 2022-03-14 0001564590-22-009929
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -3.15 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.56 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-06 0001564590-22-018528
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -3.15 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure -0.001 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093917
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093917
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.206 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093917
us-gaap EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent pure 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-08 0000950170-24-028523
us-gaap EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent pure 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-08 0000950170-24-028523
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent pure -0.003 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093917
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure -0.001 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093917
us-gaap EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Percent pure -0.013 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093917
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure -0.001 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093917
us-gaap EffectiveIncomeTaxRateReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093917
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure -0.013 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093917
us-gaap EffectOfExchangeRateOnCashAndCashEquivalents Effect of Exchange Rate on Cash and Cash Equivalents USD 4,000 2017-07-01 2018-03-31 2018 Q3 10-Q 2018-05-10 0001193125-18-159375
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-14 0001564590-22-009929
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 14.98M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap EmployeeServiceShareBasedCompensationCashReceivedFromExerciseOfStockOptions Employee Service Share-based Compensation, Cash Received from Exercise of Stock Options (Deprecated 2017-01-31) USD 490,000 2015-07-01 2016-06-30 2016 FY 10-K 2016-09-13 0001193125-16-708358
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount USD 40.00M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap EquityMethodInvestmentRealizedGainLossOnDisposal Equity Method Investment, Realized Gain (Loss) on Disposal USD 1.30M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap FairValueAssumptionsExpectedDividendRate Fair Value Assumptions, Expected Dividend Rate (Deprecated 2018-01-31) pure 0 2011-07-01 2012-06-30 2013 FY 10-K 2013-09-27 0001193125-13-382009
us-gaap FairValueAssumptionsExpectedVolatilityRate Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31) pure 0.9 2011-07-01 2012-06-30 2013 FY 10-K 2013-09-27 0001193125-13-382009
us-gaap FairValueAssumptionsRiskFreeInterestRate Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) pure 0 2011-07-01 2012-06-30 2013 FY 10-K 2013-09-27 0001193125-13-382009
us-gaap FairValueInputsControlPremium Fair Value Inputs, Control Premium (Deprecated 2018-01-31) pure 0.15 2011-07-01 2011-12-31 2014 FY 10-K 2014-09-11 0001193125-14-338993
us-gaap FederalIncomeTaxExpenseBenefitContinuingOperations Federal Income Tax Expense (Benefit), Continuing Operations USD -13,000 2011-07-01 2012-06-30 2013 FY 10-K 2013-09-27 0001193125-13-382009
us-gaap FinanceLeaseInterestExpense Finance Lease, Interest Expense USD 12,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-10 0000950170-23-007180
us-gaap FinanceLeaseInterestPaymentOnLiability Finance Lease, Interest Payment on Liability USD 12,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-10 0000950170-23-007180
us-gaap FinanceLeaseLiability Finance Lease, Liability USD 36,000 2022-12-31 2022 FY 10-K 2023-03-10 0000950170-23-007180
us-gaap FinanceLeaseLiabilityCurrent Finance Lease, Liability, Current USD 36,000 2022-12-31 2022 FY 10-K 2023-03-10 0000950170-23-007180
us-gaap FinanceLeaseLiabilityNoncurrent Finance Lease, Liability, Noncurrent USD 36,000 2021-12-31 2022 FY 10-K 2023-03-10 0000950170-23-007180
us-gaap FinanceLeaseLiabilityPaymentsDue Finance Lease, Liability, Payment, Due USD 37,000 2022-12-31 2022 FY 10-K 2023-03-10 0000950170-23-007180
us-gaap FinanceLeaseLiabilityPaymentsDueAfterYearFive Finance Lease, Liability, to be Paid, after Year Five USD 0 2022-12-31 2022 FY 10-K 2023-03-10 0000950170-23-007180
us-gaap FinanceLeaseLiabilityPaymentsDueNextTwelveMonths Finance Lease, Liability, to be Paid, Year One USD 37,000 2022-12-31 2022 FY 10-K 2023-03-10 0000950170-23-007180
us-gaap FinanceLeaseLiabilityPaymentsDueYearFive Finance Lease, Liability, to be Paid, Year Five USD 0 2022-12-31 2022 FY 10-K 2023-03-10 0000950170-23-007180
us-gaap FinanceLeaseLiabilityPaymentsDueYearFour Finance Lease, Liability, to be Paid, Year Four USD 0 2022-12-31 2022 FY 10-K 2023-03-10 0000950170-23-007180
us-gaap FinanceLeaseLiabilityPaymentsDueYearThree Finance Lease, Liability, to be Paid, Year Three USD 0 2022-12-31 2022 FY 10-K 2023-03-10 0000950170-23-007180
us-gaap FinanceLeaseLiabilityPaymentsDueYearTwo Finance Lease, Liability, to be Paid, Year Two USD 0 2022-12-31 2022 FY 10-K 2023-03-10 0000950170-23-007180
us-gaap FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear Finance Lease, Liability, to be Paid, Remainder of Fiscal Year USD 35,000 2022-09-30 2022 Q3 10-Q 2022-11-04 0000950170-22-022141
us-gaap FinanceLeaseLiabilityUndiscountedExcessAmount Finance Lease, Liability, Undiscounted Excess Amount USD 1,000 2022-12-31 2022 FY 10-K 2023-03-10 0000950170-23-007180
us-gaap FinanceLeasePrincipalPayments Finance Lease, Principal Payments USD 87,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap FinanceLeaseRightOfUseAsset Finance Lease, Right-of-Use Asset, after Accumulated Amortization USD 33,000 2022-12-31 2022 FY 10-K 2023-03-10 0000950170-23-007180
us-gaap FinanceLeaseRightOfUseAssetAmortization Finance Lease, Right-of-Use Asset, Amortization USD 133,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-10 0000950170-23-007180
us-gaap FinanceLeaseWeightedAverageDiscountRatePercent Finance Lease, Weighted Average Discount Rate, Percent pure 0.125 2022-12-31 2022 FY 10-K 2023-03-10 0000950170-23-007180
us-gaap FinancingReceivableAllowanceForCreditLosses Financing Receivable, Allowance for Credit Loss USD 0 2024-12-31 2024 FY 10-K 2025-03-06 0000950170-25-034601
us-gaap FiniteLivedIntangibleAssetsAccumulatedAmortization Finite-Lived Intangible Assets, Accumulated Amortization USD 47.62M 2022-12-31 2022 FY 10-K 2023-03-10 0000950170-23-007180
us-gaap FinitelivedIntangibleAssetsAcquired1 Finite-lived Intangible Assets Acquired USD 0 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-07 0001564590-19-041819
us-gaap FiniteLivedIntangibleAssetsFairValueDisclosure Finite-lived Intangible Assets, Fair Value Disclosure USD 4.60M 2011-12-31 2014 FY 10-K 2014-09-11 0001193125-14-338993
us-gaap FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss Finite Lived Intangible Assets, Foreign Currency Translation Gain (Loss) USD 0 2018-07-01 2018-12-31 2018 FY 10-KT 2019-03-18 0001193125-19-078454
us-gaap FiniteLivedIntangibleAssetsGross Finite-Lived Intangible Assets, Gross USD 47.62M 2022-12-31 2022 FY 10-K 2023-03-10 0000950170-23-007180
us-gaap FiniteLivedIntangibleAssetsNet Finite-Lived Intangible Assets, Net USD 0 2022-12-31 2022 FY 10-K 2023-03-10 0000950170-23-007180
us-gaap ForeignIncomeTaxExpenseBenefitContinuingOperations Foreign Income Tax Expense (Benefit), Continuing Operations USD -167,000 2014-07-01 2015-06-30 2015 FY 10-K 2015-09-10 0001193125-15-316983
us-gaap GainLossOnDerivativeInstrumentsNetPretax Gain (Loss) on Derivative Instruments, Net, Pretax USD -45.16M 2018-01-01 2018-12-31 2019 FY 10-K 2020-03-16 0001564590-20-010956
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD 0 2015-07-01 2016-06-30 2016 FY 10-K 2016-09-13 0001193125-16-708358
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093917
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 44.89M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap ImpairmentOfIntangibleAssetsFinitelived Impairment of Intangible Assets, Finite-lived USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-08 0000950170-24-028523
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD -231.78M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093917
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -274.96M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD 100,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093917
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest USD -25.00M 2011-07-01 2012-06-30 2012 FY 10-K 2012-09-27 0001193125-12-406956
us-gaap IncomeTaxesPaid Income Taxes Paid USD 0 2016-07-01 2017-06-30 2017 FY 10-K 2017-09-13 0001193125-17-283875
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 200,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093917
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD -50,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap IncomeTaxExpenseBenefitContinuingOperations Income Tax Expense (Benefit), Continuing Operations (Deprecated 2013-01-31) USD -169,000 2011-07-01 2012-06-30 2012 FY 10-K 2012-09-27 0001193125-12-406956
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 47.72M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093917
us-gaap IncomeTaxReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-10 0000950170-23-007180
us-gaap IncomeTaxReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-10 0000950170-23-007180
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -48.65M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093917
us-gaap IncomeTaxReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount USD 715,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093917
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD 219,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093917
us-gaap IncomeTaxReconciliationPriorYearIncomeTaxes Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Amount USD 3.02M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093917
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD 147,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093917
us-gaap IncomeTaxReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Amount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093917
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD 2.99M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093917
us-gaap IncreaseDecreaseInAccountsAndOtherReceivables Increase (Decrease) in Accounts and Other Receivables USD 59,000 2018-07-01 2018-12-31 2018 FY 10-KT 2019-03-18 0001193125-19-078454
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD -298,000 2018-07-01 2018-12-31 2018 FY 10-KT 2019-03-18 0001193125-19-078454
us-gaap IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities USD -525,000 2011-07-01 2012-03-31 2012 Q3 10-Q 2012-05-10 0001193125-12-225011
us-gaap IncreaseDecreaseInAccountsPayableAndOtherOperatingLiabilities Increase (Decrease) in Accounts Payable and Other Operating Liabilities USD 756,000 2018-07-01 2018-09-30 2019 Q1 10-Q 2018-11-09 0001193125-18-323795
us-gaap IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets Increase (Decrease) in Accounts Receivable and Other Operating Assets USD -13.65M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD 94,000 2018-07-01 2018-12-31 2018 FY 10-KT 2019-03-18 0001193125-19-078454
us-gaap IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities USD 1.22M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap IncreaseDecreaseInContractWithCustomerLiability Increase (Decrease) in Contract with Customer, Liability USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD 0 2018-07-01 2018-09-30 2019 Q1 10-Q 2018-11-09 0001193125-18-323795
us-gaap IncreaseDecreaseInInventories Increase (Decrease) in Inventories USD -147,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap IncreaseDecreaseInOperatingAssets Increase (Decrease) in Operating Assets USD 212,000 2011-07-01 2012-03-31 2012 Q3 10-Q 2012-05-10 0001193125-12-225011
us-gaap IncreaseDecreaseInOtherNoncurrentAssets Increase (Decrease) in Other Noncurrent Assets USD 3.46M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap IncreaseDecreaseInOtherNoncurrentLiabilities Increase (Decrease) in Other Noncurrent Liabilities USD -16,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 652,000 2018-07-01 2018-12-31 2018 FY 10-KT 2019-03-18 0001193125-19-078454
us-gaap IncreaseDecreaseInRestrictedCash Increase (Decrease) in Restricted Cash USD 0 2015-07-01 2016-06-30 2016 FY 10-K 2016-09-13 0001193125-16-708358
us-gaap IncrementalCommonSharesAttributableToShareBasedPaymentArrangements Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements shares 0 2016-07-01 2017-06-30 2017 FY 10-K 2017-09-13 0001193125-17-283875
us-gaap InterestExpense Interest Expense USD 0 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-08 0000950170-24-093853
us-gaap InterestExpenseNonoperating InterestExpenseNonoperating USD 33,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093917
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-06 0000950170-25-034601
us-gaap InventoryFinishedGoodsNetOfReserves Inventory, Finished Goods, Net of Reserves USD 0 2025-03-31 2025 Q1 10-Q 2025-05-08 0000950170-25-066907
us-gaap InventoryNet Inventory, Net USD 1.67M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap InventoryRawMaterialsNetOfReserves Inventory, Raw Materials, Net of Reserves USD 1.01M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap InventoryWorkInProcessNetOfReserves Inventory, Work in Process, Net of Reserves USD 650,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap InventoryWriteDown Inventory Write-down USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-06 0000950170-25-034601
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 19,000 2014-07-01 2015-06-30 2015 FY 10-K 2015-09-10 0001193125-15-316983
us-gaap LeaseCost Lease, Cost USD 3.78M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 41.52M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 693,000 2022-12-31 2022 FY 10-K 2023-03-10 0000950170-23-007180
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 4.95M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 693,000 2023-12-31 2023 FY 10-K 2024-03-08 0000950170-24-028523
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 2.71M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 2.67M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 3.47M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 1.24M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 19.77M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap Liabilities Liabilities USD 57.63M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 166.14M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap LiabilitiesCurrent Liabilities, Current USD 38.51M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap LiabilitiesFairValueDisclosureRecurring Liabilities, Fair Value Disclosure, Recurring (Deprecated 2018-01-31) USD 6.96M 2018-03-31 2018 Q3 10-Q 2018-05-10 0001193125-18-159375
us-gaap LicenseAndServicesRevenue License and Services Revenue (Deprecated 2018-01-31) USD 1.13M 2017-07-01 2018-03-31 2018 Q3 10-Q 2018-05-10 0001193125-18-159375
us-gaap LineOfCreditFacilityCurrentBorrowingCapacity Line of Credit Facility, Current Borrowing Capacity USD 15.00M 2019-02-28 2018 FY 10-KT 2019-03-18 0001193125-19-078454
us-gaap LineOfCreditFacilityRemainingBorrowingCapacity Line of Credit Facility, Remaining Borrowing Capacity USD 10.00M 2019-02-28 2018 FY 10-KT 2019-03-18 0001193125-19-078454
us-gaap LitigationSettlementAmountAwardedToOtherParty Litigation Settlement, Amount Awarded to Other Party USD 4.68B 2026-07-17 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap LitigationSettlementExpense Litigation Settlement, Expense USD 200,000 2026-01-01 2026-03-31 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap LongTermDebt Long-term Debt USD 30.00M 2023-03-31 2023 Q1 10-Q 2023-05-04 0000950170-23-017724
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive Long-Term Debt, Maturity, after Year Five USD 0 2022-12-31 2022 FY 10-K 2023-03-10 0000950170-23-007180
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths Long-Term Debt, Maturity, Year One USD 9.17M 2023-03-31 2023 Q1 10-Q 2023-05-04 0000950170-23-017724
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive Long-Term Debt, Maturity, Year Five USD 833,000 2022-12-31 2022 FY 10-K 2023-03-10 0000950170-23-007180
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour Long-Term Debt, Maturity, Year Four USD 833,000 2023-03-31 2023 Q1 10-Q 2023-05-04 0000950170-23-017724
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree Long-Term Debt, Maturity, Year Three USD 10.00M 2023-03-31 2023 Q1 10-Q 2023-05-04 0000950170-23-017724
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo Long-Term Debt, Maturity, Year Two USD 10.00M 2023-03-31 2023 Q1 10-Q 2023-05-04 0000950170-23-017724
us-gaap LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear Long-Term Debt, Maturity, Remainder of Fiscal Year USD 0 2023-03-31 2023 Q1 10-Q 2023-05-04 0000950170-23-017724
us-gaap LongTermDebtNoncurrent Long-term Debt, Excluding Current Maturities USD 29.31M 2022-12-31 2023 FY 10-K 2024-03-08 0000950170-24-028523
us-gaap LossContingencyAccrualCarryingValueCurrent Loss Contingency, Accrual, Current USD 4.90M 2026-06-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap LossContingencyAccrualCarryingValuePeriodIncreaseDecrease Loss Contingency Accrual, Period Increase (Decrease) USD 200,000 2026-01-01 2026-03-31 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap LossContingencyEstimateOfPossibleLoss Loss Contingency, Estimate of Possible Loss USD 4.70M 2026-03-31 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap MarketableSecuritiesCurrent Marketable Securities, Current USD 35.01M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap MarketableSecuritiesFixedMaturities Marketable Securities, Fixed Maturities (Deprecated 2018-01-31) USD 16.40M 2012-06-30 2012 FY 10-K 2012-09-27 0001193125-12-406956
us-gaap MarketableSecuritiesUnrealizedGainLoss Marketable Securities, Unrealized Gain (Loss) USD 2,000 2016-07-01 2017-03-31 2017 Q3 10-Q 2017-05-08 0001193125-17-162489
us-gaap MoneyMarketFundsAtCarryingValue Money Market Funds, at Carrying Value USD 70.90M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 43.15M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap NetCashProvidedByUsedInFinancingActivitiesContinuingOperations Net Cash Provided by (Used in) Financing Activities, Continuing Operations USD 30.41M 2017-07-01 2018-03-31 2018 Q3 10-Q 2018-05-10 0001193125-18-159375
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD 167.95M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap NetCashProvidedByUsedInInvestingActivitiesContinuingOperations Net Cash Provided by (Used in) Investing Activities, Continuing Operations USD -15.13M 2017-07-01 2018-03-31 2018 Q3 10-Q 2018-05-10 0001193125-18-159375
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -229.71M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD -15.83M 2017-07-01 2018-03-31 2018 Q3 10-Q 2018-05-10 0001193125-18-159375
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -274.91M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap NoncashOrPartNoncashAcquisitionPayablesAssumed1 Noncash or Part Noncash Acquisition, Payables Assumed USD 1.74M 2018-01-01 2018-03-31 2019 Q1 10-Q 2019-05-10 0001193125-19-144237
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 6.52M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap OperatingExpenses Operating Expenses USD 283.44M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -281.48M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap OperatingLeaseCost Operating Lease, Cost USD 400,000 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-09 0000950170-24-056380
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 1.07M 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-03 0000950170-23-058775
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 21.76M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 2.63M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 19.12M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap OperatingLeasePayments Operating Lease, Payments USD 3.50M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 19.29M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 5.44M 2018-12-31 2019 FY 10-K 2020-03-16 0001564590-20-010956
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 826,000 2018-12-31 2019 FY 10-K 2020-03-16 0001564590-20-010956
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFiveYears Operating Leases, Future Minimum Payments, Due in Five Years USD 80,000 2017-06-30 2017 FY 10-K 2017-09-13 0001193125-17-283875
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 849,000 2018-12-31 2019 FY 10-K 2020-03-16 0001564590-20-010956
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 895,000 2018-12-31 2019 FY 10-K 2020-03-16 0001564590-20-010956
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 879,000 2018-12-31 2019 FY 10-K 2020-03-16 0001564590-20-010956
us-gaap OperatingLeasesFutureMinimumPaymentsDueThereafter Operating Leases, Future Minimum Payments, Due Thereafter USD 358,000 2014-03-31 2014 Q3 10-Q 2014-05-14 0001193125-14-198582
us-gaap OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear Operating Leases, Future Minimum Payments, Remainder of Fiscal Year USD 73,000 2014-03-31 2014 Q3 10-Q 2014-05-14 0001193125-14-198582
us-gaap OperatingLeasesRentExpenseNet Operating Leases, Rent Expense, Net USD 374,000 2018-07-01 2018-12-31 2018 FY 10-KT 2019-03-18 0001193125-19-078454
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.118 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 411,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap OtherAssets Other Assets USD 0 2018-12-31 2018 FY 10-KT 2019-03-18 0001193125-19-078454
us-gaap OtherAssetsCurrent Other Assets, Current USD 944,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 9.41M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPeriodIncreaseDecrease Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax (Deprecated 2012-01-31) USD -449,000 2011-07-01 2012-03-31 2012 Q3 10-Q 2012-05-10 0001193125-12-225011
us-gaap OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax USD 1,000 2020-01-01 2020-12-31 2021 FY 10-K 2022-03-14 0001564590-22-009929
us-gaap OtherComprehensiveIncomeLossNetOfTax Other Comprehensive Income (Loss), Net of Tax USD 164,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-06 0000950170-25-034601
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax USD -147,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax USD 0 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-09 0000950170-24-056380
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 2.75M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap OtherNonoperatingExpense Other Nonoperating Expense USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-06 0000950170-25-034601
us-gaap OtherNonoperatingIncome Other Nonoperating Income USD 6.52M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD 6.52M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap PaidInKindInterest Paid-in-Kind Interest USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-14 0001564590-22-009929
us-gaap PaymentForContingentConsiderationLiabilityFinancingActivities Payment for Contingent Consideration Liability, Financing Activities USD 15.00M 2019-01-01 2019-12-31 2020 FY 10-K 2021-03-12 0001564590-21-012894
us-gaap PaymentOfFinancingAndStockIssuanceCosts Payment of Financing and Stock Issuance Costs USD 451,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-08 0000950170-24-028523
us-gaap PaymentsForLegalSettlements Payments for Legal Settlements USD 21.52M 2026-07-17 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap PaymentsForRestructuring Payments for Restructuring USD 590,000 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-12 0001564590-21-012894
us-gaap PaymentsOfDebtExtinguishmentCosts Payment for Debt Extinguishment or Debt Prepayment Cost USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-06 0000950170-25-034601
us-gaap PaymentsOfDebtIssuanceCosts Payments of Debt Issuance Costs USD 1.34M 2019-01-01 2019-12-31 2020 FY 10-K 2021-03-12 0001564590-21-012894
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 389,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap PaymentsRelatedToTaxWithholdingForShareBasedCompensation Payment, Tax Withholding, Share-based Payment Arrangement USD 3.64M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap PaymentsToAcquireAvailableForSaleSecurities Payments to Acquire Available-for-sale Securities USD 5.05M 2016-07-01 2017-06-30 2019 FY 10-K 2020-03-16 0001564590-20-010956
us-gaap PaymentsToAcquireAvailableForSaleSecuritiesDebt Payments to Acquire Debt Securities, Available-for-sale USD 139.10M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-10 0000950170-23-007180
us-gaap PaymentsToAcquireBusinessesGross Payments to Acquire Businesses, Gross USD 15.07M 2017-07-01 2018-03-31 2018 Q3 10-Q 2018-05-10 0001193125-18-159375
us-gaap PaymentsToAcquireBusinessesNetOfCashAcquired Payments to Acquire Businesses, Net of Cash Acquired USD 16.78M 2017-07-01 2018-06-30 2019 FY 10-K 2020-03-16 0001564590-20-010956
us-gaap PaymentsToAcquireMarketableSecurities Payments to Acquire Marketable Securities USD 9.95M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 3.40M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap PensionAndOtherPostretirementBenefitExpense Pension and Other Postretirement Benefits Cost (Reversal of Cost) USD 181,000 2011-07-01 2012-06-30 2012 FY 10-K 2012-09-27 0001193125-12-406956
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 5.00M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 6.85M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 2.59M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 44.73M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap ProceedsFromIssuanceOfLongTermDebt Proceeds from Issuance of Long-term Debt USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-03-08 0000950170-24-028523
us-gaap ProceedsFromLinesOfCredit Proceeds from Lines of Credit USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-06 0000950170-25-034601
us-gaap ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale USD 124.00M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-10 0000950170-23-007180
us-gaap ProceedsFromSaleAndMaturityOfMarketableSecurities Proceeds from Sale and Maturity of Marketable Securities USD 180.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap ProceedsFromSaleOfAvailableForSaleSecurities Proceeds from Sale of Available-for-sale Securities USD 1.10M 2011-07-01 2012-06-30 2014 FY 10-K 2014-09-11 0001193125-14-338993
us-gaap ProceedsFromSaleOfEquityMethodInvestments Proceeds from Sale of Equity Method Investments USD 1.30M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap ProceedsFromSaleOfPropertyPlantAndEquipment Proceeds from Sale of Property, Plant, and Equipment USD 155,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093917
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 5.44M 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-07 0000950170-24-123267
us-gaap ProceedsFromWarrantExercises Proceeds from Warrant Exercises USD 13,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap ProductionRelatedImpairmentsOrCharges Production Related Impairments or Charges USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-06 0000950170-25-034601
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -274.91M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 15.04M 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093917
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 10.30M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap PropertySubjectToOrAvailableForOperatingLeaseNumberOfUnits Property Subject to or Available for Operating Lease, Number of Units Leases 2 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093917
us-gaap RecognitionOfDeferredRevenue Recognition of Deferred Revenue USD 0 2017-07-01 2018-06-30 2018 FY 10-K 2018-09-18 0001193125-18-276414
us-gaap RepaymentsOfLinesOfCredit Repayments of Lines of Credit USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-06 0000950170-25-034601
us-gaap RepaymentsOfLongTermDebt Repayments of Long-term Debt USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-06 0000950170-25-034601
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 237.43M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap RestrictedCash Restricted Cash USD 150,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap RestrictedCashAndCashEquivalentsNoncurrent Restricted Cash and Cash Equivalents, Noncurrent USD 150,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap RestructuringCharges Restructuring Charges USD 590,000 2020-01-01 2020-12-31 2020 FY 10-K 2021-03-12 0001564590-21-012894
us-gaap RestructuringReserve Restructuring Reserve USD 0 2020-12-31 2020 FY 10-K 2021-03-12 0001564590-21-012894
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -1.38B 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 1.96M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap RevenueRecognitionMilestoneMethodRevenueRecognized Revenue Recognition, Milestone Method, Revenue Recognized USD 25.00M 2014-07-01 2014-09-30 2017 Q1 10-Q 2016-11-08 0001193125-16-763095
us-gaap Revenues Revenues USD 2.25M 2017-07-01 2018-03-31 2018 Q3 10-Q 2018-05-10 0001193125-18-159375
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 600,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap RoyaltyRevenue Royalty Revenue (Deprecated 2018-01-31) USD 1.12M 2017-07-01 2018-03-31 2018 Q3 10-Q 2018-05-10 0001193125-18-159375
us-gaap SaleOfStockPricePerShare Sale of Stock, Price Per Share USD/shares 4 2016-01-31 2017 FY 10-K 2017-09-13 0001193125-17-283875
us-gaap SecurityDeposit Security Deposit USD 150,000 2018-03-31 2018 Q3 10-Q 2018-05-10 0001193125-18-159375
us-gaap SegmentReportingOtherItemAmount SegmentReportingOtherItemAmount USD 13.99M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap SellingAndMarketingExpense Selling and Marketing Expense USD 65,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 33.90M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value USD/shares 1.35 2017-03-31 2017 Q3 10-Q 2017-05-08 0001193125-17-162489
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2017-07-01 2018-03-31 2018 Q3 10-Q 2018-05-10 0001193125-18-159375
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.552 2017-07-01 2018-03-31 2018 Q3 10-Q 2018-05-10 0001193125-18-159375
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum pure 0.8 2015-07-01 2016-06-30 2016 FY 10-K 2016-09-13 0001193125-16-708358
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum pure 0.76 2015-07-01 2016-06-30 2016 FY 10-K 2016-09-13 0001193125-16-708358
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.017 2017-07-01 2018-03-31 2018 Q3 10-Q 2018-05-10 0001193125-18-159375
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum pure 0.013 2016-07-01 2016-09-30 2017 Q1 10-Q 2016-11-08 0001193125-16-763095
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum pure 0.012 2016-07-01 2016-09-30 2017 Q1 10-Q 2016-11-08 0001193125-16-763095
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 967,000 2015-07-01 2016-06-30 2016 FY 10-K 2016-09-13 0001193125-16-708358
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period shares 112,500 2012-07-01 2012-09-30 2014 Q1 10-Q 2013-11-13 0001193125-13-439868
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 1.38M 2017-07-01 2018-03-31 2018 Q3 10-Q 2018-05-10 0001193125-18-159375
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 482,000 2017-06-27 2017 FY 10-K 2017-09-13 0001193125-17-283875
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 2.29 2016-07-01 2016-09-30 2017 Q1 10-Q 2016-11-08 0001193125-16-763095
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares shares 875,003 2016-07-01 2016-09-30 2017 Q1 10-Q 2016-11-08 0001193125-16-763095
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 1.77 2017-06-27 2017 FY 10-K 2017-09-13 0001193125-17-283875
us-gaap SharePrice Share Price USD/shares 1.045 2017-12-22 2018 FY 10-K 2018-09-18 0001193125-18-276414
us-gaap ShortTermBorrowings Short-term Debt USD 0 2023-12-31 2023 FY 10-K 2024-03-08 0000950170-24-028523
us-gaap StockGrantedDuringPeriodValueSharebasedCompensation Shares Granted, Value, Share-based Payment Arrangement, after Forfeiture USD -3.64M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 108.51M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 0.1 2020-12-08 2020 FY 10-K 2021-03-12 0001564590-21-012894
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 2.18M 2024-04-18 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap StockIssuedDuringPeriodValueEmployeeBenefitPlan Stock Issued During Period, Value, Employee Benefit Plan USD 110,000 2009-07-01 2010-06-30 2012 FY 10-K 2012-09-27 0001193125-12-406956
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 1.07M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 44.66M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap StockIssuedDuringPeriodValueShareBasedCompensation Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture USD -1.37M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 1.45M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap UnrealizedGainLossOnDerivatives Unrealized Gain (Loss) on Derivatives USD 170,000 2011-07-01 2012-06-30 2014 FY 10-K 2014-09-11 0001193125-14-338993
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 0 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093917
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued USD 0 2025-12-31 2025 FY 10-K 2026-03-05 0001193125-26-093917
us-gaap USGovernmentSecuritiesAtCarryingValue US Government Securities, at Carrying Value USD 5.00M 2023-12-31 2024 FY 10-K 2025-03-06 0000950170-25-034601
us-gaap VariableLeaseCost Variable Lease, Cost USD 344,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 87,274 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458319
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 37.25M 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-06 0001564590-22-018528
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 87,274 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001193125-26-458319

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →